Taysha Gene Therapies is planning a webinar and invites the CLN1 disease community to submit questions about the TSHA-118 CLN1 Batten disease clinical trial to the patient advocacy groups BDSRA and BDFA. Please submit your questions by February 18, 2022, by contacting Morgan DeBoth mdeboth@bdsra.org at BDSRA. Please read the community letter here.